Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion

Recruiting

Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion

Sponsor:

Texas Cardiac Arrhythmia Research Foundation

Code:

NCT04502017

Conditions

Device-Related Thrombosis

Atrial Fibrillation

Left Atrial Appendage Occlusion

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ASA plus Clopidogrel

Genetic-Tailored AntiThrombotic Strategy

Half-Dose of novel OAC

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-15. This information was provided to ClinicalTrials.gov by Texas Cardiac Arrhythmia Research Foundation on 2020-08-07.